No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Solid Biosciences Added to the Nasdaq Biotechnology Index
William Blair Maintains Solid Biosciences(SLDB.US) With Buy Rating
Solid Biosciences Receives Buy Rating Amid Promising Developments and Accelerated Approval Prospects for SGT-003
SOLiD Awarded NTIA Grant for Open RAN Development Project
PepGen Stock Craters 35% on FDA Clinical Hold
Solid Biosciences Positioned For Next-Gen Duchenne Muscular Dystrophy Treatment Success: Analyst